Benjamin Morris Greenberg, MD $$

Benjamin M. Greenberg, M.D., M.H.S., is a professor and the Cain Denius Scholar in Mobility Disorders in the Department of Neurology and Neurotherapeutics and the Department of Pediatrics at UT Southwestern Medical Center. 

He received a Master of Health Sciences degree from the Johns Hopkins School of Public Health. From there, he earned his medical degree at Baylor College of Medicine and went on to complete an internship in internal medicine at Rush-St. Luke's-Presbyterian Hospital in Chicago. He completed a residency in neurology and served as a chief resident at Johns Hopkins Hospital in Baltimore.

Prior to his recruitment to UT Southwestern in 2009, Dr. Greenberg was on the faculty of the Johns Hopkins Division of Neuroimmunology, serving as the director of the Encephalitis Center and co-director of the nation’s first dedicated Transverse Myelitis Center.

He serves as director of the Transverse Myelitis and Neuromyelitis Optica Program, the Pediatric Demyelinating Disease Program at Children’s Health℠ – which he established as one of only two U.S. programs of its kind – and the Neurosciences Clinical Research Center.

Dr. Greenberg is an internationally recognized expert in treating rare autoimmune disorders of the central nervous system. He is the principal investigator for the first large-scale study of pediatric TM coordinator centers throughout North America in a collaborative effort to better understand this rare disease.

Dr. Greenberg splits his clinical time between adult and pediatric patients, routinely consulting on the inpatient units of William P. Clements University Hospital, Parkland Memorial Hospital and Children’s Medical Center.

His research focuses on better diagnosing, prognosticating and treating demyelinating diseases and nervous system infections. He also coordinates clinical trials to evaluate new treatments to prevent neurologic damage and restore function to affected patients.

In addition, Dr. Greenberg has led an effort to improve biorepository development and create uniform protocols for sample handling and analysis. As part of this initiative, his collaborative research has identified novel biomarkers that may be key to distinguishing between patients with various neurologic disorders.

Certified by the American Board of Psychiatry and Neurology, Dr. Greenberg is a three-time Texas Monthly Rising Star.